How do we evaluate an inadequate response in a patient with rheumatoid arthritis in the clinical praxis P?;¿Cómo se evalúa una respuesta inadecuada en un paciente con artritis reumatoide en la práctica clínica?

Reumatologia Clinica

Volumn 3, Issue 1, 2007, Pages 38-44

  Balsa, Alejandro ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

ACR; Activity indexes; DAS; Improvement indexes; Rheumatoid arthritis; SDAJ

Indexed keywords

CHRONIC DISEASE; CLINICAL ASSESSMENT TOOL; DISABILITY; DISEASE ACTIVITY; DISEASE CONTROL; EARLY INTERVENTION; FUNCTIONAL STATUS; HUMAN; JOINT DESTRUCTION; OUTCOME ASSESSMENT; QUALITY OF LIFE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; TREATMENT PLANNING; TREATMENT RESPONSE;

EID: 34047264782     PISSN: 1699258X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1699-258X(07)73597-0     Document Type: Review

References (39)

1. Griffith J, Carr A. What is the impact of early rheumatoid arthritis on the individual? Best Pract Res Clin Rheumatol. 2001;15:77-90.
2. Quinn MA, Conaghan PG, Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology (Oxford). 2001;40:1211-20.
3. Pincus T, Gibofsky A, Weinblatt ME. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum. 2002;46:851-4.
4. Tugwell P, Boers M, Baker P, Wells G, Snider J. Endpoints in rheumatoid arthritis. J Rheumatol. 1994;21 Suppl 42:2-8.
5. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff MC, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36:729-40.
6. Boers M, Tugwell P, Felson DT, Van Riel PL, Kirwan JR, Edmonds JP, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl. 1994;41:86-9.
7. Smolen JS. The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Br J Rheumatol. 1992;31:219-20.
8. Tugwell P, Bombardier C. A methodologic framework for developing and selecting endpoints in clinical trials. J Rheumatol. 1982;9:758-62.
9. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol. 1993;20:555-6.
10. Boers M, Tugwell P. The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. J Rheumatol. 1993;20:568-74.
11. Roberts RS. Pooled outcome measures in arthritis: the pros and cons. J Rheumatol. 1993;20:566-7.
12. Paulus HE, Egger MJ, Ward JR, Williams HJ. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis Rheum. 1990;33:477-84.
13. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38:727-35.
14. Siegel JN, Zhen BG. Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in favor. Arthritis Rheum. 2005;52:1637-41.
15. Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am. 2006;32:9-44.
16. Van der Heijde DM, Van't Hof MA, Van Riel PL. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990;49:916-20.
17. Prevoo ML, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van-de PLB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-8.
18. Fuchs HA, Brooks R, Callahan LF, Pincus T. A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum. 1989;32:531-7.
19. Van Gestel AM, Haagsma CJ, Van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41:1845-50.
20. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42:244-57.
21. Eberl G, Studnicka-Benke A, Hitzelhammer H, Gschnait F, Smolen JS. Development of a disease activity index for the assessment of reactive arthritis (DAREA). Rheumatology (Oxford). 2000;39:148-55.
22. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23 5 Suppl 39:S100-8.
23. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7:R796-806.
24. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004;364:263-9.
25. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol. 2003;215 Suppl 31:S154-7.
26. Van Riel PL, Fransen J. To be in remission or not: is that the question? Ann Rheum Dis. 2005;64:1389-90.
27. Pinals RS, Baum J, Bland J, Fosdick WM, Kaplan SB, Masi AT, et al. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981;24:1308-15.
28. Balsa A, Carmona L, González-Alvaro I, Belmonte MA, Tena X, Sanmarti R. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol. 2004;31:40-6.
29. Makinen H, Kautiainen H, Hannonen P, Sokka T. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis. 2005;64:1410-3.
30. Prevoo ML, Van Gestel AM, Van HT, Van Rijswijk MH, Van-de PLB, Van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996;35:1101-5.
31. Van Riel PL, Van Gestel AM. Clinical outcome measures in rheumatoid arthritis. Ann Rheum Dis. 2000;59 Suppl 1:28-31.
32. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004;50:36-42.
33. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford). 2004;43: 1252-5.
34. Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum. 2005;52:2625-36.
35. Landewe R, Van der HD, Van Der LS, Boers M. Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission. Ann Rheum Dis. 2006;65:637-41.
36. Van der HD, Klareskog L, Boers M, Landewe R, Codreanu C, Bolosiu HD, et al. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis. 2005;64:1582-7.
37. Van Gestel AM, Prevoo ML, Van't Hof MA, Van Rijswijk MH, Van-de PLB, Van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum. 1996;39:34-40.
38. Van GA, Anderson JJ, Van Riel PL, Boers M, Haagsma CJ, Rich B, et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis. J Rheumatol. 1999;26:705-11.
39. Villaverde V, Balsa A, Cantalejo M, Fernandez-Prada M, Madero MR, Munoz-Fernandez S, et al. Activity indexes in rheumatoid arthritis. J Rheumatol. 2000;27:2576-81.